GB0009895292 (GB0009895292)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 7/9, Altman Z 3.0 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency demonstrates a robust economic moat, evidenced by an ROIC of 13.3% that significantly outpaces the cost of equity at 7.6%, yielding a positive spread of +5.7%. This profitability is primarily driven by exceptional margin expansion rather than operational leverage or financial gearing; a gross margin of 81.9% combined with a net margin of 17.4% suggests strong pricing power and high-value delivery, while the DuPont decomposition points to margins as the dominant ROE driver alongside steady revenue growth of 8.6%. Creditworthiness and fundamental stability are further corroborated by a Piotroski F-Score of 7/9 and an Altman Z-Score of 3.0, indicating a low probability of financial distress and strong balance sheet health relative to peers.
Valuation metrics present a divergence between current market pricing and intrinsic value models. The stock trades at a P/E multiple of 28.4x, which requires assessment against historical averages and sector benchmarks to determine if the premium is justified by growth expectations or represents overvaluation. Conversely, the DCF model assigns a fair value of $137, implying that current market prices may differ from this calculated intrinsic worth based on projected cash flows and assumed terminal growth rates. The gap between these two valuation anchors highlights where investor sentiment diverges from discounted cash flow assumptions regarding future earnings sustainability.
Risk assessment reveals no specific negative deltas in the provided dataset; however, the high gross margin of 81.9% introduces sensitivity to input cost fluctuations or regulatory changes that could compress spreads given the low variable-cost structure implied by such margins. The absence of insider activity data limits insight into management's immediate confidence levels relative to current share prices. Ultimately, the risk-reward profile hinges on whether the market is appropriately pricing a high-growth trajectory consistent with the 8.6% revenue expansion or if it has already factored in potential margin erosion from such elevated profitability levels.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6% | 7.6% | 9.6% |
|---|---|---|---|
| 2% | $165 | $114 | $80 |
| 3% | $217 | $137 | $91 |
| 4% | $320 | $172 | $106 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=7.6%, terminal growth 3%. Fair value $137 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like EFA or IEFA, the fund manager is mechanically forced to buy or sell GB0009895292 shares regardless of GB0009895292's individual fundamentals. We estimate $4.0B of passive capital is structurally linked to GB0009895292 through 6 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in GB0009895292 to visualize passive redemption contagion across ETFs and collateral stocks.
If GB0009895292 (GB0009895292) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 3 ETFs with GB0009895292. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
GB0009895292 Ownership Dynamics
ETFs with Highest GB0009895292 Exposure
Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
GB0009895292 Capital Efficiency
How efficiently does GB0009895292 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
GB0009895292 converts 44% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 56% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 5.7% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare GB0009895292 to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.